By
From the * Divisions of Experimental Medicine and Hematology/Oncology, Beth Israel Deaconess
Medical Center, West Campus, Harvard Institutes of Medicine, Harvard Medical School, Boston,
Massachusetts 02215; and the Division of Hematology/Oncology, Oregon Health Sciences Center,
Portland, Oregon 97201
The related adhesion focal tyrosine kinase (RAFTK), a recently discovered member of the focal adhesion kinase family, has previously been reported to participate in signal transduction in neuronal cells, megakaryocytes, and B lymphocytes. We have found that RAFTK is constitutively expressed in human T cells and is rapidly phosphorylated upon the activation of the T cell receptor (TCR). This activation also results in an increase in the autophosphorylation and kinase activity of RAFTK. After its stimulation, there was an increase in the association of the src cytoplasmic tyrosine kinase Fyn and the adapter protein Grb2. This association was mediated through the SH2 domains of Fyn and Grb2. RAFTK also co-immunoprecipitates with the SH2 domain of Lck and with the cytoskeletal protein paxillin through its COOH-terminal proline-rich domain. The tyrosine phosphorylation of RAFTK after T cell receptor-mediated stimulation was reduced by the pretreatment of cells with cytochalasin D, suggesting the role of the cytoskeleton in this process. These observations indicate that RAFTK participates in T cell receptor signaling and may act to link signals from the cell surface to the cytoskeleton and thereby affect the host immune response.
Transduction of signals from cell surface receptors involves the activation of numerous molecules having
catalytic activity related to phosphorylation. In the case of
signaling after the ligation of the TCR/CD3, there is the
associated release of calcium, activation of intracytoplasmic
protein tyrosine kinases including Fyn and Lck, modulation
in phosphatidylinositol metabolism with phosphorylation
of PLC- Although considerable knowledge has been generated on
such pathways in the T cell response to antigen, there is still
much to be learned, particularly regarding the interactions of
kinase signaling molecules with the cytoskeletal proteins. One
recent study revealed that activation via TCR/CD3 led to important associations and changes in the actin cytoskeleton (17).
We and others have recently identified a novel signaling
molecule known as related adhesion focal tyrosine kinase
(RAFTK)1, Pyk2, or CAK- We have observed that RAFTK is phosphorylated in response to the activation of certain integrins in B lymphocytes (25) and megakaryocytes (26). The induced phosphorylation of RAFTK via calcium-mediated ion channel
pathways and after stress activation has been shown in PC12 pheochromocytoma cells (19, 27, 28).
We report the finding that RAFTK is expressed in human T lymphocytes and participates in signaling events
triggered by the ligation of the TCR/CD3 complex. We
have characterized several of the interacting molecules that
associate with RAFTK in human T cells, including the cytoskeletal protein paxillin. These studies provide new information regarding the regulation of pathways of T cell
receptor signaling and the associated cytoskeletal changes that may mediate the cellular immune response.
Cells and Cell Cultures.
The permanent human T cell lines
Jurkat and H9 were obtained from the American Type Culture
Collection (Rockville, MD) and shown to be mycoplasma-free
before their expansion in culture. The cells were carried in DME
with 10% FCS, 2 mM glutamine, 50 µg/ml penicillin, and 50 µg/
ml streptomycin. Primary human PBLs were obtained from normal volunteers after obtaining their informed consent and then isolated by Ficoll Hypaque density centrifugation as previously described (29). The anti-CD3-producing hybridoma (OKT-3) was
obtained from the American Type Culture Collection and grown
in IMDM with 20% FCS. For antibody production, cells were
grown in serum- and protein-free hybridoma medium (Sigma Chemical Co., St. Louis, MO) containing Nutridoma-HU 1%
(Boehringer Mannheim, Indianapolis, IN).
Reagents and Materials.
The lectin PHA was obtained from
Pharmacia Biotech (Piscataway, NJ) and the nitrocellulose membrane from BioRad Laboratories (Hercules, CA). The anti-CD3
antibody X35 was obtained from Immunotech (Westbrook, ME),
and OKT-3 was purified from OKT-3-producing hybridoma supernatants on protein A-Sepharose columns. Antibodies to Fyn were obtained from Santa Cruz Biotechnology (Santa Cruz, CA)
and Transduction Laboratories (Lexington, KY). Anti-paxillin antibody was obtained from ICN Biomedicals, Inc. (Costa Mesa, CA).
Specific polyclonal antibodies to RAFTK were generated by immunizing New Zealand white rabbits with a bacterially expressed
fusion protein consisting of GST and the COOH terminus (amino
acids 681-1,009) of the human RAFTK cDNA subcloned into
the pGEX-2T expression vector as described (26). The sera were
titered against the GST-RAFTK COOH-terminal fusion protein
by ELISA, and the serum (R-4250) that revealed the highest titer
was used in the subsequent experiments. This antiserum was shown
to be specific and not cross-reactive with FAK in earlier experiments (26). Electrophoresis reagents were obtained from BioRad
Laboratories. The protease inhibitors leupeptin, aprotinin, and alpha 1 antitrypsin and all other reagents were obtained from Sigma
Chemical Co.
Stimulation of Cells.
Cells were washed twice with HBSS,
(GIBCO BRL, Gaithersburg, MD) and resuspended at 5 × 106
cells/ml in DME. Cells were stimulated with either PHA (10 µg/ ml), Immunoprecipitation and Western Blot Analysis.
For immunoprecipitation studies, identical amounts of protein from each sample
were clarified by incubation with protein A-Sepharose CL-4B
(Pharmacia Biotech) for 1 h at 4°C. After the removal of protein
A-Sepharose by brief centrifugation, the solution was incubated
with different primary antibodies as detailed below for each experiment for 4 h or overnight at 4°C. Immunoprecipitations of
the antibody-antigen complexes were performed by incubation for 2 h at 4°C with 75 µl of protein A-Sepharose (10% suspension). Nonspecific bound proteins were removed by washing the
Sepharose beads three times with modified RIPA buffer and one
time with PBS. Bound proteins were solubilized in 40 µl of 2×
Laemmli buffer and further analyzed by immunoblotting. Samples were separated on 7.5% SDS-PAGE and then transferred to
nitrocellulose membranes. The membranes were blocked with 5%
nonfat milk protein and probed with primary antibody for 3 h at
room temperature (RT) or 4°C overnight. Immunoreactive
bands were visualized using HRP-conjugated secondary antibody
and the enhanced chemiluminescent system (Amersham Corp.,
Arlington Heights, IL). Monoclonal antibody (4G10, IgG2a) was
used for Western blot analysis of phosphotyrosine protein.
Glutathione S Transferase Fusion Protein Binding Studies.
The RAFTK
COOH-terminal domain (amino acids 681 through 1,009) Glutathione S transferase (GST) fusion protein was amplified by the
PCR technique and cloned into the pGEX-2T expression vector (Pharmacia Biotech) as previously described (26). The GST-
fusion protein was produced by 1 mM isopropyl Kinase Assays.
The immunoprecipitated complexes obtained
by immunoprecipitating cell lysates with RAFTK antiserum were
washed twice with RIPA buffer and once in kinase buffer (20 mM
Hepes, pH 7.4, 50 mM NaCl, 5 mM MgCl2, 5 mM MnCl2, 100 mM Na3VO4, and 5 µM ATP). For in vitro kinase assays, the immune complex was incubated in kinase buffer containing 25 µg
of poly (Glu/Tyr, 4:1; 20-50 kD; Sigma Chemical Co.) and 5 µCi
[32P]ATP at RT for 30 min.
Autophosphorylation Assay.
This assay was carried out by incubating the immune complex in a kinase buffer containing 5 µCi
[32P]ATP at RT for 30 min. The reaction was stopped by adding
4× SDS sample buffer and by boiling the sample for 5 min. Proteins were then separated on SDS-PAGE and detected by autoradiography.
To further characterize the signaling pathways in human T cells involved in
the immune response, we used as models two permanent T cell lines, Jurkat and H9, as well as primary human PBLs.
Analysis by immunoblotting (data not shown) or immunoprecipitation revealed abundant RAFTK protein in these T
cells (Fig. 1).
The stimulation of human T cell lines with T cell receptor ligation induces the tyrosine phosphorylation of a phosphoprotein around 115 kD (5, 7). We therefore investigated whether various stimuli associated with such T cell
activation modulated the phosphorylation of RAFTK, which
has a deduced molecular weight of ~120 kD. As seen in
Fig. 1, A and B, an increase in the tyrosine phosphorylation
of RAFTK could be specifically observed in the T cell lines
Jurkat or H9 after T cell receptor ligation or treatment with
the lectin PHA. The membrane was then stripped and reprobed with anti-RAFTK antibody to confirm that equivalent amounts of RAFTK were loaded in each lane (Fig. 1,
A and B, bottom). Stimulation of primary PBLs with anti-T
cell receptor antibody also induced an increase in the tyrosine phosphorylation of RAFTK (Fig. 1 C).
To determine the time course of tyrosine phosphorylation of RAFTK, Jurkat cells were stimulated with anti-T
cell receptor antibody ×35, OKT-3, or with the lectin
PHA. Ligation of the TCR/CD3 by monoclonal antibody
×35 or OKT-3 reached a maximum by 2.5-5 min, and
declined thereafter (Fig. 2, A and B). PHA stimulation resulted in an increased tyrosine phosphorylation by 5 min
that declined slightly thereafter with substantial phosphorylation still detectable at 20 min (Fig. 2 C). Anti-RAFTK
immunoblotting of the anti-RAFTK immunoprecipitates
showed that the ~115-kD phosphotyrosine polypeptide
corresponds to the RAFTK protein (Fig. 2, A-C, bottom). Depending on the resolution of the gels, RAFTK was seen
to migrate either as a single band or as a doublet (Figs. 1
and 2).
The autophosphorylation and kinase activities of protein tyrosine kinases can be
activated upon their tyrosine phosphorylation, which is essential for their role in signal transduction. We therefore performed an autophosphorylation assay and an in vitro kinase assay in which poly (Glu/Tyr, 4:1) was used as an exogenous substrate to determine the intrinsic tyrosine kinase
activity of RAFTK. As shown, T cell receptor stimulation
resulted in an increase in the autophosphorylating (Fig. 3 A)
as well as the kinase activity of RAFTK (Fig. 3 B). In the autophosphorylation assays, maximal activity was observed at
~2.5-5 min. However, for the in vitro kinase assays, maximal activity was observed at ~5-10 min. The different kinetics observed in autophosphorylation versus in vitro kinase assay could be attributed to the differences in the
assays used. The in vitro kinase activity observed in the
RAFTK immune complexes using exogenous substrate
could be the result of RAFTK and other co-associated kinases such as Fyn.
To further characterize the role that RAFTK
might play in T cell signaling after its activation via TCR/
CD3 ligation, we performed immunoprecipitation studies
followed by immunoblotting. We observed a specific association of RAFTK with Fyn, a Src family kinase that is
known to be capable of associating with TCR (12, 30).
A small fraction of Fyn was readily detected as associating with RAFTK before the TCR/CD3 activation of Jurkat
cells, and this association increased after their stimulation
(Fig. 4 A).
Using GST-fusion proteins corresponding to the SH3
and SH2 domains of Fyn, we observed an association only
with the GST-SH2-Fyn protein by immunoprecipitation
of the fusion protein followed by immunoblotting with
anti-RAFTK antibody (Fig. 4 B). The SH2 domain of Lck,
another Src family member, has recently been shown to
play an important role in the initiation of signaling events after TCR stimulation (33). We also examined the association of the GST-SH2 domain of Lck with RAFTK. As
shown (Fig. 4 B), RAFTK also co-immunoprecipitates
with the GST-SH2 domain of Lck.
We then examined the ability of RAFTK to form in
vitro complexes with another SH2 and SH3 domain-containing protein, Grb2, which has been shown to interact
with RAFTK in other cells (19, 26). As shown in Fig. 5 A,
RAFTK immunoprecipitates from activated T cell lysates
associated with Grb2. To further characterize this interaction, GST-fusion proteins of the RAFTK-COOH-terminal domain, of Grb2-SH2, or of Grb2-SH3 domains were
added to the lysates of the stimulated Jurkat cells. The complexes were immunoprecipitated with Glutathione-conjugated beads and the bound proteins were detected by antiGrb2 (Fig. 5 B) or anti-RAFTK immunoblotting (Fig. 5 C).
The GST-RAFTK-COOH-terminal domain associated
with Grb2 (Fig. 5 B), whereas Sepharose beads containing
the GST-Grb2-SH2 domain bound RAFTK from the activated T cell lysates (Fig. 5 C). Beads containing only GST,
GST-NH2-terminal Grb2-SH3, or GST-COOH-terminal Grb2-SH3 failed to bind RAFTK, indicating the specificity
of these interactions (Fig. 5 C). These data clearly indicate
that the stable interaction between RAFTK and the SH2
domain of Fyn or the SH2 domain of Grb2 can be mimicked in vitro and provide additional evidence that the SH2
domain of these signaling molecules appears to be the principal determinant of RAFTK binding in vivo.
After our observation that RAFTK may be co-immunoprecipitated with molecules previously characterized as components of the TCR signaling pathways, we wished to determine whether certain cytoskeletal molecules in T cells
may also associate with this novel kinase. Using specific antibodies to RAFTK or paxillin, we found a constitutive association of these two molecules (Fig. 6 A). Using the
GST-COOH-terminal RAFTK protein, we observed a modestly increased association with paxillin after TCR/
CD3 stimulation with anti-CD3 antibody (Fig. 6 B).
To examine the effect of calcium influx on TCR-
induced activation of RAFTK, we treated Jurkat cells with
anti-CD3 antibody in the presence or absence of the calcium chelator EGTA. The TCR-induced phosphorylation
of RAFTK was partially reduced in the presence of EGTA
(Fig. 7 A). This result suggests that the phosphorylation of
RAFTK can be mediated in part by the increase in intracellular calcium concentration that is mediated by these
stimuli.
To further investigate the role of the cytoskeleton in the
tyrosine phosphorylation of RAFTK, Jurkat T cells were
preincubated for 60 min at 37°C with media alone ( Our studies indicate that RAFTK, a novel signaling
molecule that appears to be a member of the FAK family, is
present in human T lymphocytes and participates in signaling pathways after T cell activation. After the ligation of
the TCR/CD3, there was a robust phosphorylation of
RAFTK in both the model permanent T cell lines Jurkat
and H9, as well as in primary human PBLs. Furthermore, RAFTK was also activated, which was apparent both in the
enhanced autophosphorylation of RAFTK as well as the
increase in its in vitro kinase activity as determined using a
poly (Glu/Tyr, 1:4) substrate. Parallel studies using other
T cell activators, specifically the lectin PHA, revealed a similar phosphorylation of RAFTK in a time- and concentration-dependent manner. Furthermore, it appears that calcium
influx may be required for the TCR-mediated tyrosine phosphorylation of RAFTK, as depletion of extracellular calcium by EGTA partially blocked the RAFTK phosphorylation
induced by these stimuli. Pyk2/RAFTK phosphorylation
has also been shown to be associated with changes in calcium in other cell types (19, 27, 28).
It is noteworthy that after phosphorylation, RAFTK was
found to be associated with several well-characterized
components of the TCR/CD3 signaling pathways, including Fyn and Grb2. Fyn is a Src family tyrosine kinase known
to be capable of associating with the TCR/CD3 complex,
and is also believed to play an important role in initiating
the changes in phosphorylation that lead to further downstream signaling. This role has been most clearly demonstrated in studies showing the impaired development of CD4+
CD8+ thymocytes from double mutant mice rendered null
for Fyn and FAK through homologous recombination (35).
In addition, thymocytes from transgenic mice overexpressing Fyn were hyperstimulatable, and overexpression of a
catalytically inactive form of Fyn substantially inhibited
TCR-mediated activation in otherwise normal thymocytes (36). Grb2 is a well-characterized adapter molecule that is capable of associating with a number of kinases and substrates and may also act to facilitate signaling through the
enhancement of the physical association of such partners in
enzymatic reactions (37). Grb2 and Shc have also been
shown to play an important role in T cell signaling (5, 40-
42). Recently, in PC12 pheochromocytoma cells, Pyk2/
RAFTK has been shown to associate with activated src kinase. This interaction occurred through the SH2 domain
of src, which bound to the COOH terminus of Pyk2/
RAFTK (28). The SH2 domain of Fyn has also been
shown to associate with RAFTK in other cell types (26).
Also in PC12 cells, Grb2 has been reported to be associated
with Pyk2/RAFTK (19). Thus, there appears to be similarities in the associations of activated RAFTK with certain
signaling molecules in different cell types. RAFTK also associates with the SH2 domain of Lck, which has been
shown to play an important role in TCR-induced signal
transduction (33).
Our observations on RAFTK suggest that this novel signaling molecule could play a variety of roles in the transduction of T cell signals. Although further work is required
to elucidate such functions of RAFTK, the association of
RAFTK with the cytoskeletal protein paxillin provides a
direction for these future efforts. The confluence of signaling molecules and cytoskeletal components may provide a
platform for the regulated interactions of kinases and substrates and may lead to important changes in cell morphology that enable other aspects of the immune response such as
adhesion or migration. Work in adherent mesenchymal cells
indicates that the formation of the so-called focal adhesions
may facilitate the creation of these platforms and mediate cell
attachment and transduction of signals (23, 24, 43). Relatively little is known about similar mechanisms in hematopoietic cells like T lymphocytes. Recently, another member
of the FAK family, termed FAK B, was identified. Initial
studies indicated that FAK B may associate with ZAP-70,
an intracytoplasmic protein tyrosine kinase also capable of
associating with TCR (44). Amino acid sequence analysis
demonstrates that RAFTK is not FAK B; however, future studies of the possible association of RAFTK with FAK B
or with stimulatory molecules like ZAP-70 will be of value
in elucidating these signaling mechanisms.
There is relatively limited information available on the
convergence of protein tyrosine kinases and cytoskeletal elements in T lymphocytes. Several T cell surface structures,
including CD11a/CD18 and CD44, associate with the cytoskeleton upon receptor cross-linking. Recently, the interaction of the It has been suggested that in addition to FAK B, FAK
may also participate in regulatory events after T lymphocyte
activation (45). These earlier data, in conjunction with the
results from our study, strongly suggest that molecules like
FAK and RAFTK are important in coordinating a repertoire of kinases and adapter molecules in T cells, which then
are capable of transmitting regulated signals downstream to
the transcriptional activators that modulate gene expression.
In this regard, in the PC12 neuronal cell model, Pyk2/
RAFTK activation coupled stress signals to the c-Jun-NH2 terminal kinase pathway (27). This pathway is known to
activate AP-1 and has been previously reported to participate in T lymphocyte signaling after costimulation (46, 47).
Our future focus will be to assess whether inherited or acquired abnormalities in T cell function involve the activation and subsequent associative functions of RAFTK as it
colocalizes signaling molecules with the cytoskeleton, and
how this may be linked to transcriptional activation.
, and changes in the Ras pathway (1). Associated with these activation events, there are changes within the
cytoplasm that include alterations in the cytoskeleton (14).
(18). This molecule is
most closely related to the focal adhesion kinase (FAK).
FAK has been shown to associate with several signaling
molecules and cytoskeletal structures that form in the socalled focal adhesions upon cell attachment to extracellular substrates (21). RAFTK has considerable deduced amino
acid and structural similarity with FAK, including consensus motifs in the central catalytic domain, the absence of a
transmembrane region, myristylation sites, and SH2 and
SH3 domains. Also, similar to FAK, RAFTK has a prolinerich region in the COOH-terminal domain (18).
-CD3 antibodies ×35 (10 µg/ml), or OKT-3 (10 µg/ml)
at 37°C for various time periods. In some experiments, cells were
pretreated with EGTA (5 mM) for 5 min at 4°C or cytochalasin D
(2 µM) for 60 min at 37°C before stimulation. After stimulation,
2 × 107 cells were microfuged for 10 s and lysed in 1 ml of modified radioimmunoprecipitation assay (RIPA) buffer (50 mM
Tris-HCl, pH 7.4, 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM PMSF, 10 µg/ml of aprotinin, leupeptin, and
pepstatin, 10 mM sodium vanadate, 10 mM sodium fluoride, and
10 mM sodium pyrophosphate). Total cell lysates were clarified
by centrifugation at 10,000 g for 10 min. Protein concentrations
were determined by protein assay (BioRad Laboratories).
-thiogalactopyranoside induction and purified on a Glutathione-Sepharose
column by affinity chromatography according to manufacturer's
recommendations (Pharmacia Biotech). GST-fusion protein Grb2SH3 NH2-terminal domain, Grb2-SH3 COOH-terminal domain,
Grb2-SH2 domain, and Fyn-SH2 and -SH3 domains were purchased from Santa Cruz Biotechnology. For the binding experiments, 1 mg of cell lysate was mixed with 5 µg of GST-fusion protein and incubated for 1 h at 4°C on a rotatory shaker. GST protein (Santa Cruz Biotechnology) was used as control. 50 µl of
Glutathione-Sepharose 4B beads (Pharmacia Biotech) were added to preabsorb the complex. After incubation for 3 h at 4°C on a rotatory shaker, the beads were centrifuged and washed three times with modified RIPA buffer. The bound proteins were eluted by
boiling in Laemmli sample buffer and subjected to 7.5% SDSPAGE and Western blot analysis.
RAFTK Is Expressed in Human T Lymphocytes and Is
Phosphorylated upon T Cell Activation.
Fig. 1.
Tyrosine phosphorylation of RAFTK by T cell receptor cross-linking in Jurkat and H9 human T cell lines or primary human PBLs. Cells were
lysed in RIPA buffer. Lysates obtained from 2 × 107 unstimulated (),
-CD3-stimulated or PHA-stimulated Jurkat cells (A), H9 cells (B), or primary
human PBLs (C) were immunoprecipitated with RAFTK polyclonal antibody. Immunoprecipitates were size-fractionated on 7.5% SDS-PAGE gels,
transferred to nitrocellulose membranes, and then subjected to serial immunoblotting with anti-phosphotyrosine antibody (4G10; top) and anti-RAFTK
antibody (bottom). Normal rabbit serum (NRS) was used as a negative control. TCL, total cell lysates.
[View Larger Versions of these Images (19 + 31K GIF file)]
Fig. 2.
Time course of tyrosine phosphorylation of RAFTK upon T cell activation. Jurkat cells (5 × 106/ml) were incubated at 37°C for different
time periods with either (A) anti-CD3 antibodies ×35 (10 µg/ml), (B) OKT-3 (10 µg/ml), or (C) PHA (10 µg/ml). Stimulated or unstimulated cells
were lysed in RIPA buffer, immunoprecipitated with anti-RAFTK antibody, resolved on SDS-PAGE gels, and subjected to serial immunoblotting with anti-phosphotyrosine antibody (top) and RAFTK antibody (bottom).
[View Larger Versions of these Images (22 + 42K GIF file)]
Fig. 3.
RAFTK activation after T cell receptor stimulation. Unstimulated or stimulated Jurkat cell lysates were immunoprecipitated with
RAFTK antibody. The immune complexes were either subjected to autophosphorylating activity (A) or in vitro kinase assays, using poly (Glu/
Tyr, 4:1) substrate (B). The 32P-incorporated proteins were resolved on
7.5% SDS-PAGE followed by autoradiography.
[View Larger Version of this Image (59K GIF file)]
Fig. 4.
Association of RAFTK with Fyn and the SH2 domain of
Lck. (A) Jurkat cells unstimulated or stimulated with anti-CD3 antibody OKT-3 (10 µg/ml) for different time periods were lysed in RIPA buffer
and immunoprecipitated with RAFTK antibody. Immunoprecipitated complexes were resolved on 7.5% SDS-PAGE and immunoblotted with either anti-Fyn antibody (A, top) or RAFTK antibody (A, bottom). (B)
Stimulated Jurkat cell lysates were incubated with GST-Fyn SH2 or SH3,
or GST-Lck SH2 fusion proteins which were immunoprecipitated with
Glutathione beads. The immunoprecipitates were run on 7.5% gels, transferred onto nitrocellulose membranes, and blotted with RAFTK antibody. GST protein only was used as a control.
[View Larger Versions of these Images (37 + 21K GIF file)]
Fig. 5.
Association of RAFTK and the adapter protein Grb2 after T
cell activation. Cell lysates from Jurkat cells unstimulated or stimulated
with anti-CD3 antibody for different time periods were immunoprecipitated with RAFTK antibody. (A) The immune complexes were resolved
on 12.5% SDS-PAGE and immunoblotted with anti-Grb2 antibody. (B)
Cell lysates were immunoprecipitated with the COOH terminus of
RAFTK GST-fusion protein, run on 12.5% SDS-PAGE and blotted with
Grb2 antibody. (C) The cell lysates were immunoprecipitated with the
SH3 and SH2 domains of Grb2 and blotted with RAFTK antibody.
[View Larger Versions of these Images (21 + 22 + 22K GIF file)]
Fig. 6.
Association of RAFTK with the cytoskeletal protein paxillin.
(A) Unstimulated or stimulated Jurkat cell lysates were immunoprecipitated with RAFTK antibody, separated on 7.5% gels, and immunoblotted with
paxillin antibody. (B) In other experiments, the GST RAFTK COOH-terminal domain protein or GST protein alone as a control was added to unstimulated or stimulated Jurkat cell lysates and immunoprecipitated with
Glutathione-Sepharose beads followed by immunoblotting with anti-
paxillin antibody.
[View Larger Version of this Image (29K GIF file)]
Fig. 7.
TCR-stimulated tyrosine phosphorylation of RAFTK partly
requires calcium and an intact cytoskeleton. Jurkat cells were preincubated with medium plus EGTA (5 mM) or medium alone for 5 min at
4°C (A). Similarly, cells were also preincubated with cytochalasin D (2 µM;
+CD) or medium alone (CD) for 60 min at 37°C (B). Unstimulated cells (
) or cells stimulated for different time periods at 37°C with antiCD3 monoclonal antibody were lysed and immunoprecipitated with
RAFTK antibody. The immunoprecipitated complexes were resolved on
7.5% SDS-PAGE and immunoblotted with anti-phosphotyrosine antibody (top), and then stripped and reblotted with antiserum to RAFTK (bottom).
[View Larger Version of this Image (42K GIF file)]
CD)
or with media plus cytochalasin D (+ CD) before TCR
stimulation. Cytochalasin D is known to disrupt the cytoskeletal structure in T lymphocytes and other cells (14,
17, 34). The phosphorylation of RAFTK was reduced after
the cytochalasin D treatment of cells (Fig. 7 B). No change
in the levels of RAFTK proteins was observed under these conditions (Fig. 7 B). These results suggest that an intact
cytoskeleton is important in RAFTK phosphorylation after
TCR stimulation.
chain of TCR with the actin cytoskeleton upon T cell activation was demonstrated (17). Our
results revealed that RAFTK co-associates with paxillin, a
major component of the cytoskeleton. Like FAK, the proline-rich COOH terminus of RAFTK binds to paxillin
(24). Furthermore, the pretreatment of cells with cytochalasin D results in the reduced tyrosine phosphorylation of
RAFTK upon T cell receptor activation. This result suggests that RAFTK phosphorylation may require the formation of a cytoskeletal complex, which provides a foundation for the interactions and compartmentalization of kinases
and substrates. Future studies will further define whether
other cytoskeletal components are associated with RAFTK
upon T cell activation.
Address correspondence to Dr. Jerome Groopman, Divisions of Experimental Medicine and Hematology/ Oncology, Beth Israel Deaconess Medical Center, West Campus, Harvard Institutes of Medicine, Harvard Medical School, 1 Deaconess Rd., Boston, MA 02215.
Received for publication 4 November 1996 and in revised form 15 January 1997.
1Abbreviations used in this paper: FAK, focal adhesion kinase; GST, Glutathione S transferase; RAFTK, related adhesion focal tyrosine kinase; RIPA, radioimmunoprecipitation assay; RT, room temperature.We thank our colleagues Zhong-Ying Liu and Jian-Feng Wang for their technical assistance. We would also like to thank Dr. David J. McConkey and Dr. Dananagoud Hiregowdara for their helpful discussions. We are grateful to Janet Delahanty for her editing and preparation of the figures and to Jennifer McGrath and Evelyn Gould for their assistance with the figures for this manuscript. Finally, we appreciate Tee Trac for her typing assistance and Delroy Heath for facilitating our receipt of the needed reagents for the experiments. This paper is dedicated to the memory of our colleague Dr. Dananagoud Hiregowdara.
This work was supported in part by National Institutes of Health grants HL 53745-02, HL 43510-07, HL 55187-01, HL 51456-02, and HL 55445-01, and the David Geffen Foundation.
1. | Chan, A.C., B.A. Irving, and A. Weiss. 1992. New insights into T-cell antigen receptor structure and signal transduction. Curr. Opin. Immunol. 4: 246-251 [Medline]. |
2. |
Donovan, J.A.,
R.L. Wange,
W.Y. Langdon, and
L.E. Samelson.
1994.
The protein product of the c-cbl protooncogene is the 120 Kd tyrosine-phosphorylated protein in
Jurkat cells activated via the T cell antigen receptor.
J. Biol.
Chem.
269:
22921-22924
|
3. |
Exley, M.,
L. Varticovski,
M. Peter,
J. Sancho, and
C. Terhorst.
1994.
Association of phosphatidylinositol 3-kinase with
a specific sequence of the T cell receptor zeta chain is dependent on T cell activation.
J. Biol. Chem.
269:
15140-15146
|
4. |
Fukazawa, T.,
K.A. Reedquist,
G. Panchamoorthy,
S. Soltoff,
T. Trub,
B. Druker,
L. Cantley,
S.E. Shoelson, and
H. Band.
1995.
T cell activation-dependent association between the
p85 subunit of the phosphatidylinositol 3-kinase and Grb2/
phospholipase C-gamma 1-binding phosphotyrosyl protein
pp36/38.
J. Biol. Chem.
270:
20177-20182
|
5. |
Motto, D.G.,
S.E. Ross,
J.K. Jackman,
Q. Sun,
A.L. Olson,
P.R. Findell, and
G.A. Koretzky.
1994.
In vivo association of
Grb2 with pp116, a substrate of the T cell antigen receptoractivated protein tyrosine kinase.
J. Biol. Chem.
269:
21608-21613
|
6. | Wange, R.L., and L.E. Samelson. 1996. Complex complexes: signaling at the TCR. Immunity. 5: 197-205 [Medline]. |
7. |
Hsi, E.D.,
J.N. Siegel,
Y. Minami,
E.T. Luong,
R.D. Klausner, and
L.E. Samelson.
1988.
T cell activation induces rapid
tyrosine phosphorylation of a limited number of cellular substrates.
J. Biol. Chem.
264:
10836-10842
|
8. | Janeway, C.A., Jr, and K. Bottomly. 1994. Signals and signs for lymphocyte responses. Cell. 76: 275-285 [Medline]. |
9. | Klausner, R.D., and L.E. Samelson. 1996. T cell antigen receptor activation pathways: the tyrosine kinase connection. Cell. 64: 875-878 . |
10. |
Nel, A.E.,
S. Gupta,
L. Lee,
J.A. Ledbetter, and
S.B. Kanner.
1995.
Ligation of the T-cell antigen receptor (TCR) induces
association of hSos1, ZAP-70, phospholipase C-gamma 1, and other phosphoproteins with Grb2 and the zeta-chain of
the TCR.
J. Biol. Chem.
270:
18428-18436
|
11. | Straus, D.B., and A. Weiss. 1992. Genetic evidence for the involvement of the Lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell. 70: 585-593 [Medline]. |
12. | Gauen, L.K.T., A.N. Kong, L.E. Samelson, and A.S. Shaw. 1992. p59fyn tyrosine kinase associates with multiple T-cell receptor subunits through its unique amino-terminal domain. Mol. Cell Biol. 12: 5438-5446 [Abstract]. |
13. |
Tsygankov, A.Y.,
B.M. Broker,
J. Fargnoli,
J.A. Ledbetter, and
J.B. Bolen.
1992.
Activation of tyrosine kinase p60fyn
following T cell antigen receptor cross-linking.
J. Biol. Chem.
267:
18259-18262
|
14. | Valitutti, S., M. Dessing, K. Aktories, H. Gallati, and A. Lanzavecchia. 1995. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton. J. Exp. Med. 181: 577-584 [Abstract]. |
15. | Dubois, T., J.P. Oudinet, F. Russo-Marie, and B. Rothhut. 1995. In vivo and in vitro phosphorylation of annexin II in T cells: potential regulation by annexin V. Biochem. J. 310: 243-248 [Medline]. |
16. |
Egerton, M.,
W.H. Burgess,
D. Chen,
B.J. Druker,
A. Bretscher, and
L.E. Samelson.
1992.
Identification of ezrin as
an 81 Kd tyrosine-phosphorylated protein in T cells.
J. Immunol.
149:
1847-1852
|
17. | Rozdzial, M.M., B. Malissen, and T.H. Finkel. 1995. Tyrosine-phosphorylated T cell receptor zeta chain associates with the actin cytoskeleton upon activation of mature T lymphocytes. Immunity. 3: 623-633 [Medline]. |
18. |
Avraham, S.A.,
R. London,
Y. Fu,
S. Ota,
D. Hiregowdara,
J. Li,
S. Jiang,
L.M. Pasztor,
R.A. White,
J.E. Groopman, and
H. Avraham.
1995.
Identification and characterization of
a novel related adhesion focal tyrosine kinase (RAFTK) from
megakaryocytes and brain.
J. Biol. Chem.
270:
27742-27751
|
19. | Lev, S., H. Moreno, R. Martinez, P. Canoll, E. Peles, J.M. Musacchio, G.D. Plowman, B. Rudy, and J. Schlessinger. 1995. Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions. Nature (Lond.). 376: 737-745 [Medline]. |
20. |
Sasaki, H.,
K. Nagura,
M. Ishino,
H. Tobioka,
K. Kotani, and
T. Sasaki.
1995.
Cloning and characterization of cell adhesion kinase beta, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily.
J. Biol. Chem.
270:
21206-21219
|
21. | Burridge, K., C.E. Turner, and L.H. Romer. 1992. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J. Cell Biol. 119: 893-903 [Abstract]. |
22. | Hanks, S.K., M.B. Calalb, M.C. Harper, and S.K. Patel. 1992. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc. Natl. Acad. Sci. USA. 89: 8487-8491 [Abstract]. |
23. | Richardson, A., and J.T. Parsons. 1995. Signal transduction through integrins: a central role for focal adhesion kinase? BioEssays. 17: 229-236 [Medline]. |
24. | Clark, E.A., and J.S. Brugge. 1995. Integrins and signal transduction pathways: the road taken. Science (Wash. DC). 268: 233-239 [Medline]. |
25. |
Astier, A.,
H. Avraham,
S.N. Manie,
J.E. Groopman,
T. Canty,
S. Avraham, and
A.S. Freedman.
1997.
The related
adhesion focal tyrosine kinase (RAFTK) is tyrosine phosphorylated after ![]() |
26. |
Li, J.,
H. Avraham,
R.A. Rogers,
S. Raja, and
S. Avraham.
1996.
Characterization of RAFTK, a novel focal adhesion kinase, and its integrin-dependent phosphorylation and activation in megakaryocytes.
Blood.
88:
417-428
|
27. | Tokiwa, G., I. Dikic, S. Lev, and J. Schlessinger. 1996. Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science (Wash. DC). 273: 792-794 [Abstract]. |
28. | Dikic, I., G. Tokiwa, S. Lev, S.A. Courtneidge, and J. Schlessinger. 1996. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature (Lond.). 383: 547-550 [Medline]. |
29. | Boyum, A. 1968. Isolation and removal of lymphocytes from bone marrow of rats and guinea-pigs. Scand. J. Clin. Lab. Invest. 97(Suppl.):91-106. |
30. |
Katagiri, T.,
K. Urakawa,
Y. Yamanashi,
K. Semba,
T. Takahashi,
K. Toyoshima,
T. Yamamoto, and
K. Kano.
1989.
Overexpression of src family gene for tyrosine-kinase p59fyn
in CD4![]() ![]() |
31. | Prasad, K.V., O. Janssen, R. Kapeller, M. Raab, L.C. Cantley, and C.E. Rudd. 1993. Src-homology 3 domain of protein kinase p59fyn mediates binding to phosphatidylinositol 3-kinase in T cells. Proc. Natl. Acad. Sci. USA. 90: 7366-7370 [Abstract]. |
32. | Samelson, L.E., A.F. Phillips, E.T. Luong, and R.D. Klausner. 1990. Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor. Proc. Natl. Acad. Sci. USA. 87: 4358-4362 [Abstract]. |
33. |
Straus, D.B.,
A.C. Chan,
B. Patai, and
A. Weiss.
1996.
SH2
domain function is essential for the role of the Lck tyrosine
kinase in T-cell receptor signal transduction.
J. Biol. Chem.
271:
9976-9981
|
34. | Prat, A.G., Y.F. Xiao, D.A. Ausiello, and H.F. Cantiello. 1995. cAMP-independent regulation of CFTR by the actin cytoskeleton. Am. J. Physiol. 268: 1552-1561 . |
35. |
Kanazawa, S.,
I. Dusko,
M. Hashiyama,
T. Noumura,
T. Yamamoto,
T. Suda, and
S. Aizawa.
1996.
p59fyn-p125FAK
cooperation in development of CD4+CD8+ thymocytes.
Blood.
87:
865-870
|
36. | Cooke, M.P., K.M. Abraham, K.A. Forbush, and R.M. Perlmutter. 1991. Regulation of T cell receptor signaling by a src family protein-tyrosine kinase (p59fyn). Cell. 65: 281-291 [Medline]. |
37. | Li, N., A. Batzer, R. Daly, V. Yajnik, E. Skolnik, P. Chardin, D. Bar-Sagi, B. Margolis, and J. Schlessinger. 1993. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature (Lond.). 363: 85-88 [Medline]. |
38. | Koch, C.A., D. Anderson, M.F. Moran, C. Ellis, and T. Pawson. 1991. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science (Wash. DC). 252: 668-674 [Medline]. |
39. | Pawson, T., and G.D. Gish. 1992. SH2 and SH3 domains: from structure to function. Cell. 71: 359-362 [Medline]. |
40. |
Meisner, H.,
B.R. Conway,
D. Hartley, and
M.P. Czech.
1995.
Interactions of Cbl with Grb2 and phosphatidylinositol
3![]() |
41. |
Fukazawa, T.,
K.A. Reedquist,
T. Trub,
S. Soltoff,
G. Panchamoorthy,
B. Druker,
L. Cantley,
S.E. Shoelson, and
H. Band.
1995.
The SH3 domain-binding T cell tyrosyl phosphoprotein p120. Demonstration of its identity with the c-cbl
protooncogene product and in vivo complexes with Fyn, Grb2,
and phosphatidylinositol 3-kinase.
J. Biol. Chem.
270:
19141-19150
|
42. | Ravichandran, K.S., K.K. Lee, Z. Songyang, L.C. Cantley, P. Burn, and S.J. Burakoff. 1993. Interaction of Shc with the zeta chain of the T cell receptor upon T cell activation. Science (Wash. DC). 262: 902-905 [Medline]. |
43. | Schlaepfer, D.D., S.K. Hanks, T. Hunter, and P. van der Geer. 1994. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature (Lond.). 372: 786-791 [Medline]. |
44. |
Kanner, S.B.,
A. Aruffo, and
P.Y. Chan.
1994.
Lymphocyte
antigen receptor activation of a focal adhesion kinase-related
tyrosine kinase substrate.
Proc. Natl. Acad. Sci. USA.
91:
10484-10487
|
45. |
Maguire, J.E.,
K.M. Danahey,
L.C. Burkly, and
G.A. van
Seventer.
1995.
T cell receptor- and ![]() |
46. | Su, B., E. Jacinto, M. Hibi, T. Kallunki, M. Karin, and Y. Ben-Neriah. 1994. JNK is involved in signal integration during costimulation of T lymphocytes. Cell. 77: 727-736 [Medline]. |
47. |
del Arco, P.G.,
S. Martinez-Martinez,
V. Calvo,
A.L. Armesilla, and
J.M. Redondo.
1996.
JNK (c-Jun NH2-terminal kinase) is a target for antioxidants in T lymphocytes.
J.
Biol. Chem.
271:
26335-26340
|